Evidence map›Paper›PMID 41702708›Full record

ArticleGenome research2026

Mapping and quantifying nascent transcript start sites using TT-TSS-seq.

Eleanor Elgood Hunt, Claudia Vivori, Richard Mitter, Vedis Agnadottir, Folkert J van Werven

Abstract read
In one paragraph

Article in Genome research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Eleanor Elgood HuntThe Francis Crick Institute, London, NW1 1AT, United Kingdom.ORCID 0000-0001-6197-8609
Claudia VivoriThe Francis Crick Institute, London, NW1 1AT, United Kingdom.ORCID 0000-0001-7008-0593
Richard MitterThe Francis Crick Institute, London, NW1 1AT, United Kingdom.ORCID 0000-0002-1279-3760
Vedis AgnadottirThe Francis Crick Institute, London, NW1 1AT, United Kingdom.ORCID 0009-0002-9156-0478
Folkert J van WervenThe Francis Crick Institute, London, NW1 1AT, United Kingdom folkert.vanwerven@crick.ac.uk.ORCID 0000-0002-6685-2084

Funding

Wellcome Trust CC2043
6 · The paper itself

Abstract

Transcription initiation is a highly dynamic and tightly regulated process involving the coordinated action of transcription factors, chromatin remodelers, and RNA polymerase, which determine where and when transcription begins. Accurately mapping and quantifying transcription start sites (TSSs) from nascently transcribed RNAs remains a key area of interest, as it provides critical insights into transcription dynamics. Here, we combine transient transcriptome sequencing with transcription start site sequencing (TT-TSS-seq) to accurately map and quantify transcription initiation sites from nascent transcripts. Because transient metabolic labeling yields low-input RNA, we optimize the TSS-seq protocol to enhance sensitivity and accuracy. Specifically, we refine enzymatic reactions for decapping and RNA ligation and incorporate 5' oligonucleotides containing unique molecular identifiers (UMIs) and barcodes to enable accurate quantification and sample multiplexing. The TT-TSS-seq approach detects transcription initiation of unstable transcripts, such as enhancer RNAs. Moreover, we show that a large fraction of genes use multiple transcription initiation sites, yet often produce only a single stable transcript. Overall, TT-TSS-seq provides precise mapping and quantification of transcription initiation sites, offering new insights into transcriptional dynamics and expanding the toolkit for studying gene regulation.

Indexed as

Sequence Analysis, RNATranscription Initiation SiteAnimalsChromosome MappingEnhancer RNAsGene Expression ProfilingHumansTranscription, GeneticTranscriptomeEnhancer RNAs

Identifiers

PMID41702708
PMCPMC12951945

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.